Trial Profile
Study of Baxdela in patients with complicated urinary tract infections
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2016
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary)
- Indications Urinary tract infections
- Focus Therapeutic Use
- 04 Nov 2016 New trial record